Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Introgen Therapeutics -- Ignore unavailable to you. Want to Upgrade?

To: zeta1961 who wrote (543)	7/3/2006 10:49:34 AM
From: Jibacoa	Read Replies (1) \| Respond to of 802

Perhaps Nance will make up his losses in this company.. It seems he will have to wait a little longer. <g> The present B/A is 13.50/13.75 & that's is still somewhat lower than the price above the $35 level last August. I am not sure how much ING paid for its shares, but I think it probably was at $27.50 in July 2005 & I don't think they sold any of its shares on the spike to $36 in August.<g> However, SPA has been making a base in the last few weeks & if it can close above the $14.75 H of June 5 it could get to test the resistance at 16.25 <g> bigcharts.marketwatch.com RAGL Bernard